Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)
Titel:
Association of the circulating lipid panel, PCPro, with clinical outcomes in metastatic hormone-sensitive prostate cancer: post hoc analysis of the ENZAMET phase III randomised trial (ANZUP 1304)
Auteur:
Lin, H.-M. Scheinberg, T. Portman, N. Kim, R.M.N. Mellor, R. Huynh, K. Faulkner, A.N. Mellett, N.A. Davis, I.D. Martin, A. Sullivan, D. Joshua, A. McJannett, M. Subhash, V. Yip, S. Azad, A.A. Marschner, I.C. North, S.A. McDermott, R.S. Chi, K.N. Stockler, M.R. Sweeney, C.J. Meikle, P.J. Horvath, L.G.